(Q53199617)

12 May 2018

title

Alzheimer's amyloid of another flavour. (English)

1 reference

12 May 2018

author name string

Selkoe DJ

series ordinal

1

1 reference

12 May 2018

language of work or name

English

0 references

publication date

1 October 1995

1 reference

12 May 2018

published in

Nature Medicine

1 reference

12 May 2018

volume

1

1 reference

12 May 2018

issue

10

1 reference

12 May 2018

page(s)

998-999

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1038/nm1095-998

exact match

0 references

cites work

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-998

Beta APP mRNA transcription is increased in cultured fibroblasts from the familial Alzheimer's disease-1 family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-998

GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-998

Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-998

An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-998

7 January 2021

Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-998

7 January 2021

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-998

7 January 2021

Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome).

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-998

7 January 2021

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-998

7 January 2021

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-998

7 January 2021

Re-evaluation of the structural organization of neuritic plaques in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-998

7 January 2021

Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques.

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-998

7 January 2021

Identifiers

DOI

10.1038/NM1095-998

1 reference

12 May 2018

1 reference

12 May 2018